Abstract
A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Current Traditional Medicine
Title:Traditional Medicine - A Possible Stop Codon for COVID-19
Volume: 7 Issue: 4
Author(s): Nissar A. Reshi, Anup S. Deshpande, Namita A. Raytekar and Vasudeo P. Zambare*
Affiliation:
- Department of Life Sciences, School of Science, Sandip University, Nashik, Maharashtra,India
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Abstract: A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Export Options
About this article
Cite this article as:
Reshi A. Nissar, Deshpande S. Anup , Raytekar A. Namita and Zambare P. Vasudeo *, Traditional Medicine - A Possible Stop Codon for COVID-19, Current Traditional Medicine 2021; 7 (4) . https://dx.doi.org/10.2174/2215083806999201130103521
DOI https://dx.doi.org/10.2174/2215083806999201130103521 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MIF and the Genetic Basis of Macrophage Responsiveness
Current Immunology Reviews (Discontinued) Modulators of Protein-Protein Interactions – Novel Approaches in Targeting Protein Kinases and Other Pharmaceutically Relevant Biomolecules
Current Topics in Medicinal Chemistry Immunological Approaches for HIV Therapy
Current Drug Targets - Infectious Disorders The Role of Alterations in Arachidonic Acid Metabolism and Nitric Oxide Homeostasis in Rat Models of Diabetes During Early Pregnancy
Current Pharmaceutical Design N-Heterocyclic Dronic Acids: Applications and Synthesis
Mini-Reviews in Medicinal Chemistry Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs
Medicinal Chemistry Role of Nitric Oxide in Liver Injury
Current Molecular Medicine Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets Parallel Synthesis of a Biased Library of Thiazolidinones as Novel Sodium Channel Antagonists
Combinatorial Chemistry & High Throughput Screening Mucoadhesive Chitosan Derivatives as Novel Drug Carriers
Current Pharmaceutical Design Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Current Medicinal Chemistry Early Growth Response-1 (EGR-1) – A Key player in Myocardial Cell Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry A Clinical Update and Global Economic Burden of Rheumatoid Arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets The Pathology and Immunology of Atopic Dermatitis
Inflammation & Allergy - Drug Targets (Discontinued) Endocannabinoids in the Central Nervous System: From Neuronal Networks to Behavior
Current Drug Targets - CNS & Neurological Disorders The Multidrug Resistance Mechanisms and their Interactions with the Radiopharmaceutical Probes Used for an In Vivo Detection
Current Drug Metabolism Subject Index To Volume 6
Current Topics in Medicinal Chemistry Allergy and Inflammation: An Immunological and Therapeutic Approach
Recent Patents on Inflammation & Allergy Drug Discovery